Special considerations: children and adolescents Several GLP-1RAs, including liraglutide and dulaglutide, are approved for treating children and adolescents with type 2 diabetes
These unknowns represent the gap that formal clinical trials would address
GLP-1 drugs were originally used to treat diabetes, but are now prescribed as wonder drugs for managing weight, with millions of Americans and celebrities touting their transformations
Krauss says
Since CoQ10 is fat-soluble, lipid carriers, softgels, emulsified powders, or beadlet technologies may improve consumer experience compared with plain crystalline powder
At the same time, AOD-9604 remains the least conclusively supported of the three, given its primary clinical trial found no significant effect versus placebo